Tag: Phase I Trial
Company Announces First Patient Dosing with Peanut Allergy Vaccine
PROTECT Trial is evaluating the safety and tolerability of VLP Peanut.
ALK Starts Clinical Trial of SLIT Tablet to Treat Peanut Allergy
Sublingual Immunotherapy is administered via medications placed under the tongue.
Peanut Allergy Immunotherapy Toothpaste Makes Strides Toward Phase 2 Trial
Phase 1 study amended after two cohorts show no significant adverse events.
Aquestive’s Sublingual Epinephrine Achieves Therapeutic Blood Concentrations Following Administration
Company presented top level Phase 1 results at #AAAAI2022 meeting.
Positive Early Results with Fecal Microbiota Therapy for Peanut-Allergic Patients
Encapsulated stool from non-allergic donors alters the immune system and increases tolerance to peanuts.
Intranasal Peanut Allergy Vaccine Takes Step Forward
Company is considering vaccines for multiple food allergies including milk, tree nuts and shellfish.
Food Allergy Toothpaste Therapy: Positive News from Ongoing Phase 1 Trial
No significant adverse events in any patient during ongoing Phase 1 trial.
Sublingual Emergency Epinephrine Takes Another Step Forward in Phase 1 Study
Aquestive's postage-stamp-sized film is designed to dissolve under the tongue to provide epinephrine.
Alladapt Enrolling Participants for Clinical Study of OIT Therapy to Treat...
The study is still seeking participants 4-55 years of age.
Aquestive Charts Ambitious Path Forward for Sublingual Emergency Epinephrine
Company updates the public on status of their candidate drug administered under the tongue.
